⌘K

Login Start Free

Home/Filings/4/0000950170-25-093844

4//SEC Filing

Dube Michael P 4

Accession 0000950170-25-093844

CIK 0001652130other

View on SEC.gov Company Profile

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 4:07 PM ET

Size

4.8 KB

Accession

0000950170-25-093844

Insider Transaction Report

Form 4

Period: 2025-07-02

Intellia Therapeutics, Inc.NTLA

VP, Chief Accounting Officer

Transactions

Sale
Common Stock
2025-07-02$9.95/sh−2,503$24,905→ 57,137 total

Footnotes (1)

[F1]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on July 1, 2025, and does not represent a volitional trade by the Reporting Person.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Intellia Therapeutics, Inc.

CIK 0001652130

Entity typeother

Related Parties

1

filerCIK 0002019493

Filing Metadata

Form type: 4
Filed: Jul 2, 8:00 PM ET
Accepted: Jul 3, 4:07 PM ET
Size: 4.8 KB

View on SEC.gov